BNTC

SEC filing BNTC Appoints David Friedman as Director, Grants 35,000 Stock Options, Megan Boston Resigns from Board

3d ago

SEC filing BNTC Reports Q3 2026 Loss of $0.24 per Share, $11.9M Net Loss

19d ago

News E.F. Hutton Serves as Exclusive M&A Advisor to Smartkem on Proposed Acquisition of Carbonium Core, Inc.

117d ago

News Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

142d ago

Scanner Unusual volume (z=3.1)

165d ago